Searchable abstracts of presentations at key conferences in endocrinology

ea0010s38 | Endocrinology of bone diseases: recent clinical and basic developments | SFE2005

Hormonal assays for calcitrophic hormones – PTH and FGF 23

Fraser W

Intact PTH [PTH(1–84)] measurements separate hypercalcaemic patients into 1) a parathyroid cause (usually 1°HPT) from 2) non-parathyroid causes (usually hypercalcaemia of malignancy). Improved sensitivity increases confidence in diagnosing hypoparathyroidism. PTH RIAs had problems with C-terminal PTH fragments and in renal failure circulating PTH (35–84) persists for hours giving high RIA PTH. Intact PTH is retained in renal failure and this resulted in new ap...

ea0031p62 | Clinical practice/governance and case reports | SFEBES2013

Management of intercurrent illness in adrenal insufficiency

McLatchie Rachel , Strachan Mark W.J. , Gibb Fraser W.

Several recent publications have advocated that patients with primary and secondary adrenal insufficiency (PAI and SAI) be given emergency injectable hydrocortisone to reduce the risk of adrenal crisis. There is a limited evidence-base for this recommendation and consequently the Edinburgh Centre for Endocrinology (ECE) does not routinely issue kits to its patients. This study assessed the frequency of hospital presentations in ECE’s AI patients, and the severity of their...

ea0005p5 | Bone | BES2003

Determination of a correlation between release of beta c-terminal telopeptides and area of resorption by recombinant rankl-generated human osteoclasts

Chan B , Buckley K , Dutton J , Gallagher J , Fraser W

The discovery of the fundamental involvement of receptor activator for nuclear factor-KB ligand (RANKL) in osteoclast (OC) formation, has enabled the routine generation of human OCs in vitro from human peripheral blood mononuclear cells (PBMCs). Beta C-terminal telopeptide (beta-CTx) is a specific resorption marker for degradation of bone type I collagen by OCs. We have evaluated the correlation between beta-CTx released from dentine wafers on which OC were c...

ea0009p65 | Growth and development | BES2005

Effect of active and treated acromegaly on PTH concentration, PTH target-organ sensitivity and phosphocalcium metabolism

White H , Ahmad A , Durham B , Joseph F , Fraser W , Vora J

PTH plays an important role in bone metabolism. Active acromegaly is associated with increased bone turnover. Reduction in bone turnover markers occurs following biochemical cure/control of acromegaly. We examined the effect of active acromegaly and its treatment on PTH concentration and PTH target-organ sensitivity.10 patients with active acromegaly (defined as GH nadir greater than 1mU/L following 75g oral glucose load and IGF1 above reference range) a...

ea0009p68 | Growth and development | BES2005

Effect of phosphate supplementation on PTH target-organ sensitivity during growth hormone replacement in adult growth hormone deficiency

White H , Ahmad A , Durham B , Joseph F , Fraser W , Vora J

Adult Growth Hormone Deficiency (AGHD) is associated with relative phosphate deficiency. Phosphate is an important determinant of serum PTH concentration. PTH target-organ sensitivity is reduced in AGHD and may underlie the pathogenesis of AGHD-related osteopaenia. We examined the effect of phosphate supplementation on change in PTH target-organ sensitivity when given simultaneously with Growth Hormone Replacement (GHR) in AGHD patients.24 AGHD patients ...

ea0009p109 | Endocrine tumours and neoplasia | BES2005

Leptin and the diurnal rhythm of blood pressure

Joseph F , Ul-Haq M , Ahmad A , Whittingham P , White H , Wallace A , Fraser W , Vora J

Background: Untreated adult growth hormone deficiency (AGHD) is associated with hypertension, obesity and hyperleptinemia. Leptin is linked to obesity related hypertension, is secreted in a circadian rhythm and may contribute to the regulation of BP circadian rhythmicity.Methods: We studied the relationship between plasma leptin (half hourly samples), ambulatory systolic BP (SBP), diastolic BP (DBP) and mean arterial pressure (MAP) over a 24-h period in ...

ea0007p2 | Bone | BES2004

Does leptin regulate bone turnover in adult growth hormone deficiency?

Joseph F , Ahmad A , Wallace A , White H , Durham B , Fraser W , Vora J

Leptin stimulates osteoblastic cell proliferation, differentiation and mineralisation and inhibits osteoclast generation; leptin secretion and bone turnover are altered in adult growth hormone deficiency, a condition associated with osteoporosis. The aim of this study was to investigate leptin circadian rhythm and its association with bone turnover in untreated AGHD and following growth hormone replacement (GHR).We sampled peripheral venous blood at half...

ea0007p5 | Bone | BES2004

Growth hormone replacement is important for the restoration of PTH circadian rhythmicity in older adult growth hormone deficient patients

White H , Ahmad A , Joseph F , Prabhakar V , Patwala A , Whittingham P , Durham B , Fraser W , Vora J

Adult Growth Hormone Deficiency (AGHD) is associated with osteoporosis. PTH circadian rhythmicity is important for bone remodelling. Abnormalities in PTH circadian rhythms, including a blunted nocturnal rise, have been reported in AGHD and may contribute to osteoporosis development. GH replacement (GHR) results in improvement of PTH circadian rhythmicity and bone mineral density (BMD). In health, increasing age is associated with declining GH secretion and the appropriateness ...

ea0007p6 | Bone | BES2004

Parathyroid hormone and phosphate circadian rhythms are altered in osteopaenic adult growth hormone deficient patients

White H , Ahmad A , Joseph F , Chandran S , Corlett P , Durham B , Fraser W , Vora J

Alterations in PTH circadian rhythmicity have previously been reported in Adult Growth Hormone Deficiency (AGHD) and may contribute to the pathogenesis of AGHD-related osteoporosis. However, changes in PTH circadian rhythm have not been correlated with bone mineral density (BMD) in AGHD. Serum phosphate is a likely determinant of PTH rhythm. We examined the PTH and phosphate circadian rhythms in AGHD patients with reduced (defined as femoral neck T-score <-1.0) and normal B...

ea0007p25 | Cytokines and growth factors | BES2004

Effects of long term growth hormone replacement on leptin and body composition in adult growth hormone deficiency

Joseph F , Ahmad A , Wallace A , White H , Durham B , Fraser W , Vora J

Growth hormone (GH) and leptin regulate body composition and leptin is elevated in adult growth hormone deficiency (AGHD), a syndrome characterised by increased adiposity. We have previously shown that GH replacement for 1 month reduces 24-h mean leptin concentration independent of changes in fat mass. The long tem effects of GHR on leptin have not been described.24-h mean total leptin concentration was measured using half-hourly blood sampling, to accou...